Skip to main content
Published locations for Baseline DCP levels and NLR predict survival in patients receiving atezolizumab+bevacizumab for advanced HCC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Baseline DCP levels and NLR predict survival in patients receiving atezolizumab+bevacizumab for advanced HCC
User login
Username
Password
Reset your password
/content/baseline-dcp-levels-and-nlr-predict-survival-patients-receiving-atezolizumabbevacizumab-0
/gihepnews/article/258012/hepatocellular-carcinoma/baseline-dcp-levels-and-nlr-predict-survival